Rapid subcutaneous desensitization for the management of local and systemic hypersensitivity reactions to etanercept and adalimumab in 12 patients.
Department of Pulmonary Disease, Division of Immunology and Allergy, School of Medicine, Ankara University, Ankara, Turkey. Electronic address: bavbek@medicine.ankara.edu.tr.
Sevim
S
Bavbek
Department of Physical Medicine and Rehabilitation, Division of Rheumatology, School of Medicine, Ankara University, Ankara, Turkey.
Şebnem
Ş
Ataman
Department of Physical Medicine and Rehabilitation, School of Medicine, Hacettepe University, Ankara, Turkey.
Ayşen
A
Akıncı
Allergy and Immunology Training Program, Drug Hypersensitivity and Desensitization Center, Harvard Medical School, Brigham and Women's Hospital, Boston, Mass.
Mariana
M
Castells
D000068879:Adalimumab / Q000009:adverse effects*; D000328:Adult; D018501:Antirheumatic Agents / Q000009:adverse effects*; D003888:Desensitization, Immunologic; D004342:Drug Hypersensitivity / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D000068800:Etanercept / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012882:Skin Tests
D018501:Antirheumatic Agents; D000068879:Adalimumab; D000068800:Etanercept